Shanghai Fosun Pharmaceutical Stock Return On Asset
SFOSF Stock | USD 1.53 0.00 0.00% |
Shanghai Fosun Pharmaceutical fundamentals help investors to digest information that contributes to Shanghai Fosun's financial success or failures. It also enables traders to predict the movement of Shanghai Pink Sheet. The fundamental analysis module provides a way to measure Shanghai Fosun's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Shanghai Fosun pink sheet.
Shanghai |
Shanghai Fosun Pharmaceutical Company Return On Asset Analysis
Shanghai Fosun's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Shanghai Fosun Return On Asset | 0.0204 |
Most of Shanghai Fosun's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shanghai Fosun Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition |
Based on the latest financial disclosure, Shanghai Fosun Pharmaceutical has a Return On Asset of 0.0204. This is 100.23% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is 114.57% lower than that of the firm.
Shanghai Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Shanghai Fosun's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Shanghai Fosun could also be used in its relative valuation, which is a method of valuing Shanghai Fosun by comparing valuation metrics of similar companies.Shanghai Fosun is currently under evaluation in return on asset category among related companies.
Shanghai Fundamentals
Return On Equity | 0.0756 | |||
Return On Asset | 0.0204 | |||
Profit Margin | 0.08 % | |||
Operating Margin | 0.07 % | |||
Current Valuation | 15.52 B | |||
Shares Outstanding | 551.94 M | |||
Shares Owned By Insiders | 0.07 % | |||
Shares Owned By Institutions | 35.60 % | |||
Price To Earning | 13.80 X | |||
Price To Book | 1.45 X | |||
Price To Sales | 0.31 X | |||
Revenue | 39.01 B | |||
Gross Profit | 18.71 B | |||
EBITDA | 8.71 B | |||
Net Income | 4.74 B | |||
Cash And Equivalents | 14.64 B | |||
Cash Per Share | 5.49 X | |||
Total Debt | 9.05 B | |||
Debt To Equity | 0.64 % | |||
Current Ratio | 1.00 X | |||
Book Value Per Share | 16.30 X | |||
Cash Flow From Operations | 3.95 B | |||
Earnings Per Share | 0.21 X | |||
Number Of Employees | 36.28 K | |||
Beta | 0.76 | |||
Market Capitalization | 12.25 B | |||
Total Asset | 93.29 B | |||
Retained Earnings | 10.37 B | |||
Working Capital | (817 M) | |||
Current Asset | 10.27 B | |||
Current Liabilities | 11.09 B | |||
Z Score | 0.6 | |||
Annual Yield | 0.03 % | |||
Net Asset | 93.29 B | |||
Last Dividend Paid | 0.56 |
About Shanghai Fosun Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shanghai Fosun Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shanghai Fosun using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shanghai Fosun Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Shanghai Fosun in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Shanghai Fosun's short interest history, or implied volatility extrapolated from Shanghai Fosun options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shanghai Fosun Pharmaceutical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Shanghai Pink Sheet analysis
When running Shanghai Fosun's price analysis, check to measure Shanghai Fosun's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Fosun is operating at the current time. Most of Shanghai Fosun's value examination focuses on studying past and present price action to predict the probability of Shanghai Fosun's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Fosun's price. Additionally, you may evaluate how the addition of Shanghai Fosun to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |